Adage Capital Partners’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Adage Capital Partners’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-644,968	Closed	-$17.4M	–	957
2024 Q2	$17.4M	Sell	644,968 -255,032	-28%	-$5.3M	0.03%	473
2024 Q1	$16.5M	Sell	900,000 -100,000	-10%	-$1.59M	0.03%	500
2023 Q4	$12.3M	Buy	1,000,000 +800,000	+400%	+$7.5M	0.03%	557
2023 Q3	$3M	Buy	200,000 +50,000	+33%	+$1.04M	0.01%	718
2023 Q2	$4.87M	Buy	+150,000	New	+$5.48M	0.01%	672
2020 Q1	–	Sell	-100,000	Closed	-$4.04M	–	803
2019 Q4	$4.04M	Hold	100,000	–	–	0.01%	627
2019 Q3	$3.25M	Sell	100,000 -50,500	-34%	-$2.01M	0.01%	651
2019 Q2	$7.29M	Buy	+150,500	New	+$6.4M	0.02%	566

Other funds holding SILK

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Adage Capital Partners's SILK Position: Q3 2024 in Review

Adage Capital Partners sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 644,968 shares — an estimated $17.4M sold.

Adage Capital Partners first reported a position in SILK in Q2 2019 and held it in 8 quarters. The position peaked at $17.4M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

Adage Capital Partners reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Adage Capital Partners sold 644,968 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $17.4M.
Adage Capital Partners first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
Adage Capital Partners's Silk Road Medical, Inc. Common Stock position peaked at $17.4M in Q2 2024.
1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Adage Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.